Cardiopulmonary bypass in the treatment of malignant hyperthermia
- PMID: 4274464
- DOI: 10.1056/NEJM197405162902006
Cardiopulmonary bypass in the treatment of malignant hyperthermia
Similar articles
-
Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.N Engl J Med. 1974 May 16;290(20):1140-2. doi: 10.1056/NEJM197405162902012. N Engl J Med. 1974. PMID: 4274465 No abstract available.
-
Pathology of malignant hyperpyrexia.Br Med J. 1973 Feb 3;1(5848):249. Br Med J. 1973. PMID: 4685313 Free PMC article. No abstract available.
-
Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia.Muscle Nerve. 1987 Mar-Apr;10(3):238-41. doi: 10.1002/mus.880100307. Muscle Nerve. 1987. PMID: 2951595
-
[Etiology of malignant hyperthermia].Masui. 1975 Jun;24(6):525-37. Masui. 1975. PMID: 169408 Review. Japanese. No abstract available.
-
[Malignant hyperthermia].Recenti Prog Med. 1977 Mar;62(3):239-61. Recenti Prog Med. 1977. PMID: 141071 Review. Italian. No abstract available.
Cited by
-
Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum.Can J Vet Res. 1986 Jul;50(3):329-37. Can J Vet Res. 1986. PMID: 3742368 Free PMC article.
-
Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.Vet Res Commun. 1987;11(6):527-59. doi: 10.1007/BF00396370. Vet Res Commun. 1987. PMID: 2453969 Review. No abstract available.
-
Development of malignant hyperthermia obscured by cardiopulmonary bypass.Can Anaesth Soc J. 1986 Jul;33(4):509-14. doi: 10.1007/BF03010981. Can Anaesth Soc J. 1986. PMID: 3742327
-
Management of a malignant hyperthermia patient during cardiopulmonary bypass.Can Anaesth Soc J. 1982 Jan;29(1):50-4. doi: 10.1007/BF03007948. Can Anaesth Soc J. 1982. PMID: 6799180
MeSH terms
Substances
LinkOut - more resources
Full Text Sources